Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARTA R FERNANDEZ

Allopathic & Osteopathic Physicians General Practice

NPI
1780666750
CMS profile
528148
Location
HOLLYWOOD, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$324.00

6 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $324.00 6

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Merz North America, Inc. $151.67 2
AstraZeneca Pharmaceuticals LP $137.33 2
Janssen Pharmaceuticals, Inc $35.00 2

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARTA R FERNANDEZ

NPI 1780666750 · CMS profile ID 528148

Allopathic & Osteopathic Physicians / General Practice

HOLLYWOOD, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1780666750?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARTA R FERNANDEZ, NPI 1780666750, CMS profile ID 528148. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1780666750?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). MARTA R FERNANDEZ, NPI 1780666750, CMS profile ID 528148. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1780666750?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
MARTA R FERNANDEZ, NPI 1780666750, CMS profile ID 528148, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1780666750?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

6 matching records · $324.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 6 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–6 of 6.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merz North America, Inc. $26.6711/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950341585 CMS
Janssen Pharmaceuticals, Inc $18.7907/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885936189 CMS
AstraZeneca Pharmaceuticals LP $17.1406/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914772305 CMS
AstraZeneca Pharmaceuticals LP $120.1905/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915869881 CMS
Janssen Pharmaceuticals, Inc $16.2103/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885936195 CMS
Merz North America, Inc. $125.0001/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950341583 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $268.75 17
PY2020 $646.46 40
PY2021 $668.82 29
PY2022 $324.00 6
PY2023 $18.96 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $2,841,652.05 193
PY2024 Principal investigator $1,804,097.28 110
PY2023 Principal investigator $359,279.61 15
PY2022 Principal investigator $244,054.37 49
PY2021 Principal investigator $232,528.97 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

110 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $150.00 12/18/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143157269
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $500.00 12/18/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143157273
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,410.00 12/18/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143157277
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $54,894.00 12/18/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143157281
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $280.00 12/18/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143157284
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $750.00 12/18/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143157288
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $27,701.70 12/13/2024 Non-covered Recipient Entity
Elias Research Associates Llc
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimers Disease (ADEPT-4) No dispute reported 06/30/2026 1123477120
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152754
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152757
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152761
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152765
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152769
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152773
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152776
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152780
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152784
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152788
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152791
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152795
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152799
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152803
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152807
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152811
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152815
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152818
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152822
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152826
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152830
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152833
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152837
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152841
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152845
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152849
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152853
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152856
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152860
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152864
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152867
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152871
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152875
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152879
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152883
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152886
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152890
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152894
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152898
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152902
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152905
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152909
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152913
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152917
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152921
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152925
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152928
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152932
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,478.00 12/11/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143152936
Principal investigator 1 GlaxoSmithKline, LLC. $1,294.04 11/08/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529691
Principal investigator 1 GlaxoSmithKline, LLC. $163.34 11/08/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529693
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145931
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,137.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145935
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,672.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145938
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,478.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145942
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,725.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145946
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145949
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145953
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145957
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $48.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145960
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145964
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $42.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145968
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $140.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145972
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,687.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145976
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7,281.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145980
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,173.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145983
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,725.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145987
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145991
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145995
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143145998
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143146002
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $42.00 11/06/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143146006
Principal investigator 1 GlaxoSmithKline, LLC. $4,435.17 10/23/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 3B, OPEN-LABEL, MULTI-COUNTRY, MULTI-CENTRE, LONG-TERM FOLLOW- No dispute reported 06/30/2026 1127529709
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,000.00 10/23/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143139322
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,500.00 10/23/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143139326
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,000.00 10/23/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143139334
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10,000.00 10/23/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143139337
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $500.00 10/23/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143139341
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,500.00 10/23/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143139345
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,000.00 10/23/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143139349
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,000.00 10/23/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143139352
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138624
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138628
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138632
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138636
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $42.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138640
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,687.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138643
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7,281.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138647
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,173.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138651
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138655
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $42.00 10/09/2024 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1143138658
Principal investigator 1 GlaxoSmithKline, LLC. $2,430.15 09/25/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529697
Principal investigator 1 GlaxoSmithKline, LLC. $5,500.25 08/16/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529689
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $193,028.76 07/24/2024 Non-covered Recipient Entity
Elias Research Associates Llc
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects with Psychosis Associated with Alzheimers Disease Dementia No dispute reported 06/30/2026 1123477154
Principal investigator 1 GlaxoSmithKline, LLC. $264.83 06/20/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529701
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $20,400.00 06/18/2024 Non-covered Recipient Entity
NEW MED RESEARCH
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF AVP-786 (DEUTERATED [D6]-DEXTROMETHORPHAN HYDROBROMIDE [D6-DM]/QUINIDINE SULFATE [Q]) FOR THE TREATMENT OF AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMERS TYPE No dispute reported 06/30/2026 1118846030
Principal investigator 1 GlaxoSmithKline, LLC. $1,367.08 05/22/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529707
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,036,756.31 04/24/2024 Non-covered Recipient Entity
Elias Research Associates Llc
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimers Disease Dementia No dispute reported 06/30/2026 1123477134
Principal investigator 1 GlaxoSmithKline, LLC. $264.03 04/10/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
PHASE IIIB, OBSERVER-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTI-CENT No dispute reported 06/30/2026 1127529703
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $107,758.49 01/13/2024 Non-covered Recipient Entity
NEW MED RESEARCH
A PHASE 3, MULTICENTER, LONG-TERM, EXTENSION STUDY OF THE SAFETY AND EFFICACY OF AVP-786 (DEUTERATED [D6] DEXTROMETHORPHAN HYDROBROMIDE [D6-DM]/QUINIDINE SULFATE [Q]) FOR THE TREATMENT OF AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMERS TYPE No dispute reported 06/30/2026 1118844922
Principal investigator 1 GlaxoSmithKline, LLC. $259.69 01/12/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529695
Principal investigator 1 GlaxoSmithKline, LLC. $259.69 01/12/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529699
Principal investigator 1 GlaxoSmithKline, LLC. $1,038.75 01/12/2024 Non-covered Recipient Entity
SYSTEMS & STRUCTURE REHAB CENTER INC
A PHASE 2B, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, No dispute reported 06/30/2026 1127529705